• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(E)-3-(4-氯苯基)-3-[3-(4-氯苯基)-1H-吡唑-1-基]丙-2-烯醛

(E)-3-(4-Chloro-phen-yl)-3-[3-(4-chloro-phen-yl)-1H-pyrazol-1-yl]prop-2-enal.

作者信息

Susindran V, Athimoolam S, Bahadur S Asath, Manikannan R, Muthusubramanian S

出版信息

Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 18;66(Pt 10):o2594-5. doi: 10.1107/S1600536810035646.

DOI:10.1107/S1600536810035646
PMID:21587573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2983380/
Abstract

In the title compound, C(18)H(12)Cl(2)N(2)O, the pyrazole ring is almost planar [r.m.s. deviation = 0.002 Å] while the two chloro-phenyl rings are twisted out from the plane of the pyrazole ring, making dihedral angles of 5.3 (1) and 65.34 (4)°. In the crystal, centrosymmetric R(2) (2)(24) dimers are formed about crystallographic inversion centres through a pair of C-H⋯Cl inter-actions. These dimers are further linked through a C-H⋯O hydrogen bond, forming a C(8) chain extending along the a axis. C-H⋯π inter-actions are also observed.

摘要

在标题化合物C₁₈H₁₂Cl₂N₂O中,吡唑环几乎是平面的[r.m.s.偏差 = 0.002 Å],而两个氯苯环从吡唑环平面扭转出来,形成的二面角分别为5.3 (1)°和65.34 (4)°。在晶体中,通过一对C—H⋯Cl相互作用,围绕晶体学倒转中心形成了中心对称的R₂²(24)二聚体。这些二聚体通过C—H⋯O氢键进一步连接,形成沿a轴延伸的C₈链。还观察到C—H⋯π相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/092a8300e4ba/e-66-o2594-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/e198a680eabb/e-66-o2594-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/c8736c2037db/e-66-o2594-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/e1716b3c6ac6/e-66-o2594-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/8df3f6447ea2/e-66-o2594-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/0c2b1578b9a7/e-66-o2594-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/092a8300e4ba/e-66-o2594-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/e198a680eabb/e-66-o2594-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/c8736c2037db/e-66-o2594-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/e1716b3c6ac6/e-66-o2594-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/8df3f6447ea2/e-66-o2594-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/0c2b1578b9a7/e-66-o2594-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76e2/2983380/092a8300e4ba/e-66-o2594-fig6.jpg

相似文献

1
(E)-3-(4-Chloro-phen-yl)-3-[3-(4-chloro-phen-yl)-1H-pyrazol-1-yl]prop-2-enal.(E)-3-(4-氯苯基)-3-[3-(4-氯苯基)-1H-吡唑-1-基]丙-2-烯醛
Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 18;66(Pt 10):o2594-5. doi: 10.1107/S1600536810035646.
2
4-[(4-Chloro-phen-yl)(5-hydr-oxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)meth-yl]-5-methyl-2-phenyl-1H-pyrazol-3(2H)-one.4-[(4-氯苯基)(5-羟基-3-甲基-1-苯基-1H-吡唑-4-基)甲基]-5-甲基-2-苯基-1H-吡唑-3(2H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2008 Nov 8;64(Pt 12):o2301-2. doi: 10.1107/S1600536808036088.
3
Functionalized 3-(5-ar-yloxy-3-methyl-1-phenyl-1-pyrazol-4-yl)-1-(4-substituted-phen-yl)prop-2-en-1-ones: synthetic pathway, and the structures of six examples.功能化的3-(5-芳氧基-3-甲基-1-苯基-1-吡唑-4-基)-1-(4-取代苯基)丙-2-烯-1-酮:合成途径及六个实例的结构
Acta Crystallogr E Crystallogr Commun. 2020 Apr 21;76(Pt 5):683-691. doi: 10.1107/S2056989020005113. eCollection 2020 May 1.
4
1-[3-(4-Chloro-phen-yl)-5-(4-meth-oxy-phen-yl)-4,5-dihydro-1H-pyrazol-1-yl]butan-1-one.1-[3-(4-氯苯基)-5-(4-甲氧基苯基)-4,5-二氢-1H-吡唑-1-基]丁-1-酮
Acta Crystallogr Sect E Struct Rep Online. 2012 Apr 1;68(Pt 4):o975. doi: 10.1107/S1600536812009105. Epub 2012 Mar 7.
5
Crystal structure of (4Z)-4-[(2E)-3-(2-chloro-phen-yl)-1-hy-droxy-prop-2-en-1-yl-idene]-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one.(4Z)-4-[(2E)-3-(2-氯苯基)-1-羟基丙-2-烯-1-亚基]-3-甲基-1-苯基-1H-吡唑-5(4H)-酮的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 May 20;71(Pt 6):o407-8. doi: 10.1107/S2056989015009020. eCollection 2015 Jun 1.
6
N-[2-({[1-(4-Chloro-phen-yl)-1H-pyrazol-3-yl]-oxy}meth-yl)phen-yl]-N-meth-oxy-hydrazinecarboxamide.N-[2-({[1-(4-氯苯基)-1H-吡唑-3-基]氧基}甲基)苯基]-N-甲氧基肼甲酰胺
Acta Crystallogr Sect E Struct Rep Online. 2012 Oct 1;68(Pt 10):o2916. doi: 10.1107/S1600536812038214. Epub 2012 Sep 12.
7
(E)-1-(2,4-Dichloro-phen-yl)-3-(1,3-diphenyl-1H-pyrazol-4-yl)prop-2-en-1-one.(E)-1-(2,4-二氯苯基)-3-(1,3-二苯基-1H-吡唑-4-基)丙-2-烯-1-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Nov;67(Pt 11):o3102-3. doi: 10.1107/S1600536811044382. Epub 2011 Oct 29.
8
(E)-3-(4-Meth-oxy-phen-yl)-3-[3-(4-meth-oxy-phen-yl)-1H-pyrazol-1-yl]prop-2-enal.(E)-3-(4-甲氧基苯基)-3-[3-(4-甲氧基苯基)-1H-吡唑-1-基]丙-2-烯醛
Acta Crystallogr Sect E Struct Rep Online. 2013 Mar 28;69(Pt 4):o594-5. doi: 10.1107/S1600536813007678. Print 2013 Apr 1.
9
Crystal structure of (3,5-di-chloro-2-hy-droxy-phen-yl){1-[(naphthalen-1-yl)carbon-yl]-1H-pyrazol-4-yl}methanone.(3,5-二氯-2-羟基苯基){1-[(萘-1-基)羰基]-1H-吡唑-4-基}甲酮的晶体结构
Acta Crystallogr Sect E Struct Rep Online. 2014 Nov 19;70(Pt 12):522-4. doi: 10.1107/S1600536814024684. eCollection 2014 Dec 1.
10
(E)-3-[3-(4-Bromo-phen-yl)-1-phenyl-1H-pyrazol-4-yl]-1-(2,4-dichloro-phen-yl)prop-2-en-1-one.(E)-3-[3-(4-溴苯基)-1-苯基-1H-吡唑-4-基]-1-(2,4-二氯苯基)丙-2-烯-1-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Nov;67(Pt 11):o3104. doi: 10.1107/S1600536811044424. Epub 2011 Oct 29.

引用本文的文献

1
(E)-3-(4-Meth-oxy-phen-yl)-3-[3-(4-meth-oxy-phen-yl)-1H-pyrazol-1-yl]prop-2-enal.(E)-3-(4-甲氧基苯基)-3-[3-(4-甲氧基苯基)-1H-吡唑-1-基]丙-2-烯醛
Acta Crystallogr Sect E Struct Rep Online. 2013 Mar 28;69(Pt 4):o594-5. doi: 10.1107/S1600536813007678. Print 2013 Apr 1.
2
4,6-Bis(4-fluoro-phen-yl)-2-phenyl-1H-indazol-3(2H)-one.4,6-双(4-氟苯基)-2-苯基-1H-吲唑-3(2H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Jun 1;67(Pt 6):o1346-7. doi: 10.1107/S1600536811016369. Epub 2011 May 7.

本文引用的文献

1
Structure validation in chemical crystallography.化学晶体学中的结构验证
Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55. doi: 10.1107/S090744490804362X. Epub 2009 Jan 20.
2
5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.5-叔丁基-N-吡唑-4-基-4,5,6,7-四氢苯并[d]异恶唑-3-甲酰胺衍生物作为结核分枝杆菌泛酸合成酶的新型强效抑制剂:开启新型抗结核药物的探索
J Med Chem. 2008 Apr 10;51(7):1999-2002. doi: 10.1021/jm701372r. Epub 2008 Mar 13.
3
A short history of SHELX.
SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
4
Discovery and investigation of antiproliferative and apoptosis-inducing properties of new heterocyclic podophyllotoxin analogues accessible by a one-step multicomponent synthesis.通过一步多组分合成可获得的新型杂环鬼臼毒素类似物的抗增殖和诱导凋亡特性的发现与研究。
J Med Chem. 2007 Oct 18;50(21):5183-92. doi: 10.1021/jm070528f. Epub 2007 Sep 26.
5
Diethyl 3,8-dimethyl-4,7-diazadeca-2,8-dienedioate.3,8-二甲基-4,7-二氮杂癸-2,8-二烯二酸二乙酯
Acta Crystallogr C. 2004 Sep;60(Pt 9):o642-3. doi: 10.1107/S0108270104016130. Epub 2004 Aug 11.
6
Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids.取代吡唑-4-羧酸的合成及降血糖活性评价
Bioorg Med Chem Lett. 2002 Aug 19;12(16):2105-8. doi: 10.1016/s0960-894x(02)00380-3.
7
The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models.大麻素受体配体在小鼠腹膜炎模型中的抗炎活性。
Eur J Pharmacol. 2001 Nov 30;432(1):107-19. doi: 10.1016/s0014-2999(01)01477-7.
8
Synthesis and antiinflammatory activity of hexahydrothiopyrano[4,3-c]pyrazoles and related analogues.六氢硫代吡喃并[4,3-c]吡唑及其相关类似物的合成与抗炎活性
J Med Chem. 1982 Dec;25(12):1482-8. doi: 10.1021/jm00354a018.
9
Graph-set analysis of hydrogen-bond patterns in organic crystals.有机晶体中氢键模式的图形集分析。
Acta Crystallogr B. 1990 Apr 1;46 ( Pt 2):256-62. doi: 10.1107/s0108768189012929.
10
3,5-Diphenyl-1H-pyrazole derivatives. V--1-Acetyl-4-hydroxy-3,5-diphenyl-2-pyrazoline esters, 4-hydroxy-3,5-diphenyl-1H-pyrazole esters and N-substituted 4-(3-amino-2-hydroxy-1-propoxy)-1-methyl-3,5-diphenyl-1H-pyrazoles with antiarrhythmic, sedative and platelet antiaggregating activities.3,5-二苯基-1H-吡唑衍生物。V——具有抗心律失常、镇静和血小板抗聚集活性的1-乙酰基-4-羟基-3,5-二苯基-2-吡唑啉酯、4-羟基-3,5-二苯基-1H-吡唑酯以及N-取代的4-(3-氨基-2-羟基-1-丙氧基)-1-甲基-3,5-二苯基-1H-吡唑
Farmaco. 1990 Feb;45(2):147-66.